Join the McCarthy Institute and episode sponsor Banner and Witcoff, Ltd. for a discussion with Dr. Sarah Kagan on Biotech Patenting Around COVID-19. This session will explore patentability of therapeutics and vaccines related to COVID, ethical and social justice implications of patenting in this arena, and a review of what can be done now to counsel biotech clients with regard to patentability issues related to COVID.

When clients have new technologies they would like to protect, Dr. Sarah Kagan, PhD, JD helps them brainstorm and anticipate future uses and applications of the technology in alternative fields. Recognizing how crucial these explorations are to obtaining appropriate protection for the technology as it is currently practiced and as it may develop over the course of the life of a patent, Sarah works to protect her clients’ technologies so they will be successful in the marketplace. Capitalizing on her many years in practice, Sarah practices with an eye to the future, looking ahead to the full life cycle of a patent. Is a swift allowance of a patent application desirable? What will result in a swift allowance? Having been involved in a variety of adversarial proceedings, she constructs the foundational documents focused on future attacks, and how they can be avoided and/or rebutted. What will result in a strong patent?

GGU Presents is Golden Gate University's web-based video programming showcasing a gamut of speakers and presentations from both within and outside GGU with a broad range of unique perspectives, talents, and stories.

Watch more GGU Presents videos here: http://www.ggu.edu/ggu-presents

#GGU #GoldenGateUniversity #GGUWorldwide